# NIH Reporter #1F31HL182293-01

CFTR gene correction via targeted exon replacement

**Recipient:** University of Texas at Austin

**Award Amount:** $41,057.00
**Ceiling:** $41,057.00

**Awarded:** September 03, 2025

**Identifier:** 1F31HL182293-01

The project will investigate a gene-editing strategy intended to safely and efficiently replace CFTR exon 12, with the potential to provide a treatment for people with cystic fibrosis who lack therapeutic options.

### Description

Project to develop retron editing to replace the entire CFTR exon 12 without creating a DNA break, potentially addressing cystic fibrosis mutations that do not respond to approved CFTR modulators.

[View original record](https://reporter.nih.gov/search/a_XEnEpPR0i-06zXlbqcPw/project-details/11245313)
